A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib-Reference-Cited by-全球学者库

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib

Published:2018-08-10 Issue:12 Volume:19 Page:1097-1101
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Zhu You-cai¹,Wang Wen-xian²,Xu Chun-wei³,Zhuang Wu⁴,Song Zheng-bo²,Du Kai-qi¹,Chen Gang³,Lv Tang-feng⁵,Song Yong⁵

Affiliation:

1. Department of Thoracic Disease Diagnosis and Treatment Center Zhejiang Rongjun Hospital, Jiaxing, Zhejiang, People’s Republic of China

2. Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People’s Republic of China

3. Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People’s Republic of China

4. Department of Medical Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, People’s Republic of China

5. Department of Respiratory Medicine, Jinling Hospital, Nanjing Jiangsu, People’s Republic of China

Funder

the National Clinical Key Sepcialty Construction Program

the Science and Technology Planning Project of Zhejiang Province

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2018.1491506

Reference27 articles.

1. Cancer statistics, 2017

2. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

3. Current Treatments for Advanced Stage Non-Small Cell Lung Cancer

4. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer

5. Identifying and Targeting ROS1 Gene Fusions in Non–Small Cell Lung Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new machine learning method for cancer mutation analysis;PLOS Computational Biology;2022-10-17

2. Structural basis for RNA surveillance by the human nuclear exosome targeting (NEXT) complex;Cell;2022-06

3. Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast‐conserving surgery: a long‐term follow‐up of the SweBCG91‐RT randomised trial;Molecular Oncology;2020-09-28

4. A Catalog of 5’ Fusion Partners in ROS1-Positive NSCLC Circa 2020;JTO Clinical and Research Reports;2020-09

5. Crizotinib;Reactions Weekly;2019-01